Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Intuitive Surgical, Inc.
Intuitive Surgical, Inc. News
Intuitive Surgical, Inc. Quantitative Score
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Intuitive Surgical, Inc. Earnings & Revenue
Intuitive Surgical, Inc. Financials
Table Compare
Compare ISRG metrics with: | |||
|---|---|---|---|
Earnings & Growth | ISRG | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ISRG | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ISRG | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ISRG | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Intuitive Surgical, Inc. Income
Intuitive Surgical, Inc. Balance Sheet
Intuitive Surgical, Inc. Cash Flow
Intuitive Surgical, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Intuitive Surgical, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Intuitive Surgical, Inc. Executives
| Name | Role |
|---|---|
| Dr. Gary S. Guthart Ph.D. | Chief Executive Officer & Director |
| Mr. David J. Rosa | President & Director |
| Mr. Robert DeSantis | Executive Vice President and Chief Strategy & Corporate Operations Officer |
| Mr. Marshall L. Mohr | Executive Vice President of Global Business Services |
| Mr. Henry L. Charlton | Senior Vice President & Chief Commercial and Marketing Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Gary S. Guthart Ph.D. | Chief Executive Officer & Director | 1966 | 2.62M | |
| Mr. David J. Rosa | President & Director | Male | 1968 | 1.63M |
| Mr. Robert DeSantis | Executive Vice President and Chief Strategy & Corporate Operations Officer | Male | 1966 | 1.26M |
| Mr. Marshall L. Mohr | Executive Vice President of Global Business Services | Male | 1956 | 1.2M |
| Mr. Henry L. Charlton | Senior Vice President & Chief Commercial and Marketing Officer | Male | 1970 | 1.08M |
Intuitive Surgical, Inc. Insider Trades
| Date | 10 Oct |
| Name | LOEB GARY |
| Role | General Counsel |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 2613 |
| Date | 10 Oct |
| Name | LOEB GARY |
| Role | General Counsel |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 1178 |
| Date | 10 Oct |
| Name | LOEB GARY |
| Role | General Counsel |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 2613 |
| Date | 13 Sep |
| Name | Ladd Amy L |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 450 |
| Date | 10 Sep |
| Name | DeSantis Robert |
| Role | EVP & Chief Strategy & Corp Op |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 119 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 10 Oct | LOEB GARY | General Counsel | Acquired | M-Exempt | 2613 |
| 10 Oct | LOEB GARY | General Counsel | Disposed | F-InKind | 1178 |
| 10 Oct | LOEB GARY | General Counsel | Disposed | M-Exempt | 2613 |
| 13 Sep | Ladd Amy L | Director | Disposed | S-Sale | 450 |
| 10 Sep | DeSantis Robert | EVP & Chief Strategy & Corp Op | Acquired | M-Exempt | 119 |